Cover Image
Market Research Report

United States Cardiac Rhythm Management Devices Market Outlook to 2025

Published by GlobalData Product code 356611
Published Content info 97 Pages
Delivery time: 1-2 business days
Price
Back to Top
United States Cardiac Rhythm Management Devices Market Outlook to 2025
Published: May 1, 2018 Content info: 97 Pages
Description

GlobalData's new report, United States Cardiac Rhythm Management Devices Market Outlook to 2025, provides key market data on the United States Cardiac Rhythm Management Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD), Implantable Loop Recorders (ILR) and Pacemakers.

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size and company share data for Cardiac Rhythm Management Devices market segments - Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD), Implantable Loop Recorders (ILR) and Pacemakers.
  • Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2015 to 2025.
  • 2017 company share and distribution share data for Cardiac Rhythm Management Devices market.
  • Global corporate-level profiles of key companies operating within the United States Cardiac Rhythm Management Devices market.
  • Key players covered include Medtronic plc, Abbott Laboratories, Boston Scientific Corp. and Others.

Reasons to buy

  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.
Table of Contents
Product Code: GDMECC2972DB

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 5
  • 1.2 List of Figures 5

2 Introduction 6

  • 2.1 What Is This Report About? 6
  • 2.2 Cardiac Rhythm Management Devices Segmentation 6
  • 2.3 Definitions of Markets Covered in the Report 7

3 Cardiac Rhythm Management Devices Market, United States 9

  • 3.1 Cardiac Rhythm Management Devices Market, United States, Revenue ($m), 2015-2025 9
    • 3.1.1 Cardiac Resynchronisation Therapy (CRT) Market, United States, Revenue ($m), by Segment, 2015-2025 12
    • 3.1.2 Implantable Cardioverter Defibrillators (ICD) Market, United States, Revenue ($m), by Segment, 2015-2025 14
    • 3.1.3 Pacemakers Market, United States, Revenue ($m), by Segment, 2015-2025 16
  • 3.2 Cardiac Rhythm Management Devices Market, United States, Volume (Units), 2015-2025 18
    • 3.2.1 Cardiac Resynchronisation Therapy (CRT) Market, United States, Volume (Units), by Segment, 2015-2025 21
    • 3.2.2 Implantable Cardioverter Defibrillators (ICD) Market, United States, Volume (Units), by Segment, 2015-2025 23
    • 3.2.3 Pacemakers Market, United States, Volume (Units), by Segment, 2015-2025 25
  • 3.3 Cardiac Rhythm Management Devices Market, United States, Average Price ($) , 2015-2025 27
  • 3.4 Cardiac Rhythm Management Devices Market, United States, Distribution Share by Revenue ($m), 2017 29
  • 3.5 Cardiac Rhythm Management Devices Market, United States, Company Share by Revenue ($m), 2017 30

4 Overview of Key Companies in United States, Cardiac Rhythm Management Devices Market 32

  • 4.1 Medtronic Plc 32
    • 4.1.1 Company Overview 32
  • 4.2 Abbott Laboratories 32
    • 4.2.1 Company Overview 32
  • 4.3 Boston Scientific Corp 32
    • 4.3.1 Company Overview 32
  • 4.4 Biotronik AG 32
    • 4.4.1 Company Overview 32

5 Cardiac Rhythm Management Devices Market Pipeline Products 33

6 Financial Deals Landscape 34

  • 6.1 Acquisition 34
    • 6.1.1 Royal Philips Acquires Spectranetics 34
  • 6.2 Debt Offerings 36
    • 6.2.1 Boston Scientific Raises USD1 Billion in Public Offering of 4% Notes Due 2028 36
  • 6.3 Equity Offerings 38
    • 6.3.1 MRI Interventions Raises USD13.3 Million in Private Placement of Units 38
  • 6.4 Private Equity 40
    • 6.4.1 EBR Systems Raises USD50 Million in Financing Round 40
    • 6.4.2 3i Group to Invest USD136 Million in Cirtec Medical Systems from Century Park Capital Partners 41
  • 6.5 Venture Financing 43
    • 6.5.1 Corinnova Raises USD6.1 Million from Wellcome Trust 43
    • 6.5.2 CorInnova Raises USD0.3 Million in Venture Financing 44

7 Recent Developments 45

  • 7.1 Corporate Communications 45
    • 7.1.1 Apr 15, 2018: Genentech to Present Phase Ib/II Study Results of RG6206 45
    • 7.1.2 Apr 10, 2018: iRhythm Technologies Appoints UCLA and Cedars-Sinai Professor C. Noel Bairey Merz, M.D. to its Board of Directors 45
    • 7.1.3 Mar 13, 2018: Orthofix Announces Appointment of John Sicard to Board of Directors 46
    • 7.1.4 Feb 13, 2018: Proteus Digital Health Appoints Joseph Swedish As Board Director 46
    • 7.1.5 Jan 10, 2018: Ventripoint Appoints Head of Sales for North America 46
    • 7.1.6 Dec 19, 2017: Ventripoint Diagnostics Provides Corporate Update 47
    • 7.1.7 Nov 20, 2017: Follicum applies for the start of a Phase II study at the German Medicines Agency 47
    • 7.1.8 Oct 11, 2017: New Data Shows That for Some Patients, Deep Brain Stimulation May Address Chronic Depression 48
    • 7.1.9 Oct 04, 2017: Boston Scientific Appoints Desiree Ralls-Morrison General Counsel and Corporate Secretary 49
    • 7.1.10 Sep 05, 2017: Former U. S. Surgeon General Dr. Regina Benjamin Joins the Board of Proteus Digital Health 50
    • 7.1.11 Aug 23, 2017: Senior Novartis Executive Joins Proteus Digital Health as Chief Financial Officer 50
    • 7.1.12 Jul 20, 2017: A Third Highly Successful Ultrasound Executive joins Ventripoint 51
    • 7.1.13 Jun 21, 2017: Highly Successful Global Industry Sales & Marketing Executives Hired by Ventripoint 51
    • 7.1.14 Jun 14, 2017: Spectranetics Announces Election of New Chairperson of the Board of Directors 52
  • 7.2 Financial Announcements 52
    • 7.2.1 Apr 16, 2018: USRM Reports 2017 Financial Results 52
    • 7.2.2 Mar 28, 2018: MicroPort Scientific Announces 2017 Annual Results 53
    • 7.2.3 Mar 06, 2018: Stereotaxis Reports 2017 Fourth Quarter And Full Year Financial Results 55
    • 7.2.4 Feb 26, 2018: Orthofix International Reports Fourth Quarter And Fiscal 2017 Financial Results 56
    • 7.2.5 Feb 08, 2018: Surmodics Reports First Quarter Fiscal 2018 Results, Updates Fiscal 2018 Guidance 57
    • 7.2.6 Feb 01, 2018: Boston Scientific Announces Results for Fourth Quarter and Full Year 2017 58
    • 7.2.7 Jan 23, 2018: Glytec's Software Yields Superior Patient Outcomes According to Four New Studies in Journal of Diabetes Science and Technology 59
    • 7.2.8 Jan 09, 2018: Boston Scientific Announces Preliminary Unaudited Sales For The Fourth Quarter And Full Year Ended December 31, 2017 61
    • 7.2.9 Jan 09, 2018: Orthofix Announces Preliminary 2017 Fourth Quarter and Full Year Net Sales Results 61
    • 7.2.10 Jan 08, 2018: Stereotaxis Reports Preliminary Fourth Quarter 2017 Revenue Results 62
    • 7.2.11 Dec 12, 2017: Cyclacel Announces Presentation of Results From Phase 3 Seamless Study at Ash Annual Meeting 62
    • 7.2.12 Nov 09, 2017: Stereotaxis Reports Third Quarter 2017 Financial Results 64
    • 7.2.13 Nov 08, 2017: Surmodics Reports Fourth Quarter Fiscal 2017 Results and Provides Fiscal 2018 Guidance 65
    • 7.2.14 Nov 01, 2017: iRhythm Technologies Announces Third Quarter 2017 Financial Results And Raises Guidance For Full Year 2017 65
    • 7.2.15 Oct 30, 2017: Orthofix International Reports Third Quarter 2017 Financial Results 66
    • 7.2.16 Oct 26, 2017: Boston Scientific Announces Results For Third Quarter 2017 66
    • 7.2.17 Oct 25, 2017: Bard Announces Third Quarter Results 68
    • 7.2.18 Sep 26, 2017: Psychemedics Announces Addition of FDA-Cleared Benzodiazepines Hair Test 69
    • 7.2.19 Sep 26, 2017: DFB Soria Gives Update on Enrollment in Phase 2 Clinical Trial of SOR007 (Nanoparticle Paclitaxel) Ointment for Actinic Keratosis (AK) 71
    • 7.2.20 Aug 29, 2017: Medovex Receives Regulatory Approval from Australia's Therapeutic Goods Administration for its DenerveX System 72
    • 7.2.21 Aug 15, 2017: CareRay Exhibits At FIME 2017 74
    • 7.2.22 Aug 10, 2017: Stereotaxis Reports Second Quarter 2017 Financial Results 75

7.2.23 Aug 09, 2017: U.S. Stem Cell Reports Most Successful Financial Performance in the Company's History 76

    • 7.2.24 Aug 07, 2017: Orthofix International Reports Second Quarter 2017 Financial Results 76
    • 7.2.25 Aug 03, 2017: Surmodics Reports Third Quarter Fiscal 2017 Results and Updates Fiscal 2017 Guidance 77
    • 7.2.26 Aug 03, 2017: Spectranetics Reports Second Quarter 2017 Revenue of $74.7 million 77
    • 7.2.27 Aug 02, 2017: iRhythm Technologies Announces Second Quarter 2017 Financial Results 78
    • 7.2.28 Jul 27, 2017: Boston Scientific Announces Results for Second Quarter 2017 79
    • 7.2.29 Jun 21, 2017: Tolero Pharmaceuticals to Expand Enrollment of Phase II Study of Alvocidib in MCL-1-Dependent AML into Europe 80
    • 7.2.30 May 08, 2017: Stereotaxis Reports 2017 First Quarter Financial Results 81
    • 7.2.31 Apr 27, 2017: Boston Scientific Announces Results For First Quarter 2017 81
    • 7.2.32 Apr 27, 2017: Surmodics Reports Second Quarter Fiscal 2017 Results, Updates Fiscal 2017 Financial Guidance 82
    • 7.2.33 Apr 27, 2017: Spectranetics Reports First Quarter 2017 Revenue of $69.7 million 83
  • 7.3 Legal And Regulatory 83
    • 7.3.1 Aug 28, 2017: FDA warns US Stem Cell Clinic of significant deviations 83
    • 7.3.2 Aug 03, 2017: Zoll Announces Jury Verdict in Zoll/Philips Patent Dispute 84
    • 7.3.3 May 31, 2017: AngioDynamics Lawsuit Alleges C.R. Bard is Violating Antitrust Laws, Harming Competition and Limiting Access 84
  • 7.4 Other Significant Developments 85
    • 7.4.1 Feb 06, 2018: USRM Seeing Explosive Increase in Demand for Stem Cell Therapy 85
    • 7.4.2 Aug 28, 2017: U.S. Stem Cell Clinic Acknowledges Warning Letter By The FDA and Responds 85
    • 7.4.3 Jun 27, 2017: Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day 86
    • 7.4.4 Jun 01, 2017: Nexus Pharmaceuticals Receives FDA Approval for Sodium Nitroprusside Injection 87
  • 7.5 Product News 88
    • 7.5.1 Nov 27, 2017: Ventripoint Invents a New Way to Track Ultrasound Probes That Will Speed up Exams 88
  • 7.6 Strategy And Business Planning 89
    • 7.6.1 Feb 07, 2018: Caisson Interventional Expanding in Maple Grove 89
    • 7.6.2 Dec 11, 2017: Anthera Pharmaceuticals Announces Positive Outcome of Interim Futility Analysis in the Phase 3 RESULT Clinical Study of Sollpura 89

8 Appendix 91

  • 8.1 Research Methodology 92
    • 8.1.1 Coverage 92
    • 8.1.2 Secondary Research 92
    • 8.1.3 Primary Research 93
    • 8.1.4 Market Modeling and Forecasting 94
    • 8.1.5 Company Share Analysis 95
    • 8.1.6 Distribution Share Analysis 96
    • 8.1.7 Benchmarking 96
  • 8.2 GlobalData Consulting 96
  • 8.3 Contact Us 97
  • 8.4 Disclaimer 97

List of Tables

1.1 List of Tables

  • Table 1: Cardiac Rhythm Management Devices Market, United States, Revenue ($m), USD Constant, 2015-2020 10
  • Table 2: Cardiac Rhythm Management Devices Market, United States, Revenue ($m), USD Constant, 2021-2025 11
  • Table 3: Cardiac Resynchronisation Therapy (CRT) Market, United States, Revenue ($m), USD Constant, 2015-2020 13
  • Table 4: Cardiac Resynchronisation Therapy (CRT) Market, United States, Revenue ($m), USD Constant, 2021-2025 13
  • Table 5: Implantable Cardioverter Defibrillators (ICD) Market, United States, Revenue ($m), USD Constant, 2015-2020 15
  • Table 6: Implantable Cardioverter Defibrillators (ICD) Market, United States, Revenue ($m), USD Constant, 2021-2025 15
  • Table 7: Pacemakers Market, United States, Revenue ($m), USD Constant, 2015-2020 17
  • Table 8: Pacemakers Market, United States, Revenue ($m), USD Constant, 2021-2025 17
  • Table 9: Cardiac Rhythm Management Devices Market, United States, Volume (Units), 2015-2020 19
  • Table 10: Cardiac Rhythm Management Devices Market, United States, Volume (Units), 2021-2025 20
  • Table 11: Cardiac Resynchronisation Therapy (CRT) Market, United States, Volume (Units), 2015-2020 22
  • Table 12: Cardiac Resynchronisation Therapy (CRT) Market, United States, Volume (Units), 2021-2025 22
  • Table 13: Implantable Cardioverter Defibrillators (ICD) Market, United States, Volume (Units), 2015-2020 24
  • Table 14: Implantable Cardioverter Defibrillators (ICD) Market, United States, Volume (Units), 2021-2025 24
  • Table 15: Pacemakers Market, United States, Volume (Units), 2015-2020 26
  • Table 16: Pacemakers Market, United States, Volume (Units), 2021-2025 26
  • Table 17: Cardiac Rhythm Management Devices Market, United States, Average Price ($), 2015-2020 27
  • Table 18: Cardiac Rhythm Management Devices Market, United States, Average Price ($), 2021-2025 28
  • Table 19: Cardiac Rhythm Management Devices Market, United States, Distribution Share by Revenue ($m), USD Constant, 2017 29
  • Table 20: Cardiac Rhythm Management Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2017 31
  • Table 21: Cardiac Rhythm Management Devices Market Pipeline Products 33
  • Table 22: Royal Philips Acquires Spectranetics 34
  • Table 23: Boston Scientific Raises USD1 Billion in Public Offering of 4% Notes Due 2028 36
  • Table 24: MRI Interventions Raises USD13.3 Million in Private Placement of Units 38
  • Table 25: EBR Systems Raises USD50 Million in Financing Round 40
  • Table 26: 3i Group to Invest USD136 Million in Cirtec Medical Systems from Century Park Capital Partners 41
  • Table 27: Corinnova Raises USD6.1 Million from Wellcome Trust 43
  • Table 28: CorInnova Raises USD0.3 Million in Venture Financing 44
  • Table 29: Total Number of Primary Research Participants, Cardiovascular Devices Market, by Country 94

List of Figures

1.2 List of Figures

  • Figure 1: Cardiac Rhythm Management Devices Market, United States, Revenue ($m), USD Constant, 2015-2025 9
  • Figure 2: Cardiac Resynchronisation Therapy (CRT) Market, United States, Revenue ($m), USD Constant, 2015-2025 12
  • Figure 3: Implantable Cardioverter Defibrillators (ICD) Market, United States, Revenue ($m), USD Constant, 2015-2025 14
  • Figure 4: Pacemakers Market, United States, Revenue ($m), USD Constant, 2015-2025 16
  • Figure 5: Cardiac Rhythm Management Devices Market, United States, Volume (Units), 2015-2025 18
  • Figure 6: Cardiac Resynchronisation Therapy (CRT) Market, United States, Volume (Units), 2015-2025 21
  • Figure 7: Implantable Cardioverter Defibrillators (ICD) Market, United States, Volume (Units), 2015-2025 23
  • Figure 8: Pacemakers Market, United States, Volume (Units), 2015-2025 25
  • Figure 9: Cardiac Rhythm Management Devices Market, United States, Company Share (%) 2017 30
Back to Top